abstract: The endometrium is recognized for its remarkable regenerative and remodeling capacity. Every month this hormonally regulated organ undergoes cycles of growth (from 0.5-2 to 7 mm), regression and shedding of two-third of the tissue, leading to its monthly renewal that occurs 400 times in a woman's reproductive lifetime. Several groups have suggested the existence of a human endometrial somatic stem cell (SSC) population located around the spiral arterioles of the basalis. Different groups have isolated, identified and characterized putative endometrial SSC populations in human endometrium based on the general features of undifferentiated cells, such as slow cycling detected using the 5-bromo-2-deoxyuridine technique or identification of a side population using the Hoechst efflux dye technique. Nevertheless, specific markers to isolate these endometrial SSC have not yet been consistently elucidated. Accumulated evidence based on lineage tracing studies indicates that a surface protein named Leucine-rich repeat-containing G-protein-coupled receptor 5 (Lgr5) is a marker that can identify SSC in several tissues such as small intestine mucosa (endodermal origin), hair follicles (ectodermal origin) or mature kidney nephrons (mesodermal origin). This protein plays a crucial role in the Wnt/b-catenin signaling system by acting on the self-renewal and maintenance of the SSC population. In this work, we present novel data suggestive of Lgr5 as a putative human endometrial SSC marker, and since this is a mesoderm-derived tissue, these findings reinforce the concept that Lgr5 can be considered a universal SSC marker.
Introduction

Somatic stem cells
Somatic stem cells (SSCs) are a rare subset of cells present in adult tissues or organs which are, in essence, defined by two properties: self-renewal and multipotency. They serve as a pool of cells ready to be activated following a stress or in response to an injury, enabling the long-term maintenance of tissue homeostasis. Their accurate regulation is therefore essential. Identification and localization of SSC is difficult and laborious given the lack of specific morphological and molecular markers, although two techniques based on general SSC properties have been used. First, labeling with the DNA marker 5-bromo-2-deoxyuridine (BrdU), by its incorporation into DNA during S phase replication by substituting thymidine. As the BrdU signal progressively decreases after each division, retention of the labeling either indicates a slow division rate or a lack of division, a feature typical of SSC . Secondly, the side population (SP) method that consists of the incorporation of the cellpermeable DNA-binding dye Hoechst 33342. SSC have an almost unique ability to pump this dye out via an ATP-binding cassette membrane mechanism, which results in a low-fluorescence SP 'tail' which can be detected by flow cytometry (Goodell et al., 1996) . Different specific cell markers have been proposed for several types of SSC: CD34, described as a hematopoietic stem cell marker (Tárnok et al., 2010) ; CD44, CD90 and CD105 are associated with mesenchyme stem cells (Musumeci et al., 2011) ; Sox2 and Nestin are described as stem cell markers in neural tissues (Castinetti et al., 2011) ; c-kit and NCAM in the human liver (Strain et al., 2003) . The discovery of these markers has improved our understanding of stem cell biology in these tissues and has major clinical implications.
Implication of Wnt pathway in SSC niche
SSC reside in a specific microenvironment termed 'the niche', which varies in its location and behavior depending on the tissue (Schofield, 1978) . The signals and interactions derived by niche cells initiate the stem cell fate decisions of self-renewal or differentiation into daughter cells in order to maintain tissue homeostasis. Thus, SSC are regulated by both intrinsic signals and extracellular signals derived from niche cells (Verfaillie et al., 1999; Weissman et al., 2000; Fuchs et al., 2004; Li and Xie, 2005) . The features, structure and functions of the stem cell niche suggest that two main families of molecules guide their microenvironment: the Wnt pathway (controlling stem cell activation and cell fate decisions) and the bone morphogenetic protein (BMP) signaling pathway (which is opposed to Wnt and is responsible for stem cell inactivation; He et al., 2004) .
Wnt molecules are secreted glycoproteins that act as ligands in a complex network where they bind to cell surface receptors of the Frizzled family, initiating downstream regulation of various biological processes. Upon Wnt ligand/cell receptor interaction, three different pathways can be activated: the canonical Wnt/b-catenin signaling pathway (Clevers, 2006) , the non-canonical Wnt/Planar cell polarity pathway (Katoh, 2005) or the Wnt/Ca 2+ pathway (Kohn and Moon, 2005) .
The relevance of the canonical pathway in stem cell biology, with its central role in the accumulation of nuclear b-catenin has been demonstrated. Binding of Wnt ligands to their seven-membrane-spanning domain Frizzled receptors and LPR (low-density lipoprotein receptorrelated protein) co-receptors, promotes the destruction of the complex formed by Dvl (Dishevelled), Axin, APC (adenomatous polyposis coli), GSK-3b (glycogen synthase kinase-3b) and CK1a (casein kinase Ia) resulting in the release of b-catenin from the complex (Liu et al., 2002) . These serial events trigger the accumulation of nonubiquitinated active b-catenin in the cytoplasm after which it translocates into the nucleus. There it functions as a transcription regulator, which interacts with lymphoid enhancer/T cell factor family members to regulate the transcription of target genes such as Lgr5 gene ( Fig. 1 ; Ikeda et al., 1998; Gordon and Nusse, 2006) . In this context, Lgr5 seems to be a key gene in the regulation of the canonical Wnt signaling pathway and therefore in the activation/inhibition of cells occupying the niche.
Endometrial SSC in human and murine tissues
Human endometrium is an exceptional tissue that undergoes cycles of growth, regression and shedding during each menstrual cycle. Histologically it is composed of two layers, the lower basalis and the upper functionalis, which is renewed during the proliferative phase from the basalis that remains after menstruation (Fig. 1) . Based on these facts, Prianishnikov and Padykula hypothesized the existence of an endometrial SSC population located in the basalis (Prianishnikov, 1978 , Padykula et al., 1984 , 1989 . Label retaining cells (LRCs) have been defined as candidate in vivo SSC in the mouse reproductive tract by the BrdU method (Chan and Gargett, 2006; Cervelló et al., 2007; Szotek et al., 2007) . The LRC approach identifies SSC by their quiescent and slowly cycling nature, since they undergo only cell division during tissue turnover in order to initiate the replacement of lost cells. Therefore, putative SSC retain the label, while rapidly dividing transit amplifying cells dilute the label to undetectable levels. Hence, LRC reveal both their location and the stem cell niche. Epithelial LRC have been difficult to detect in mouse endometrium due to complete label loss over the 8-12 week chase periods following neonatal labeling (Chan and Gargett, 2006; Cervelló et al., 2007) , whereas between 6 and 9% of stromal cells were identified as LRC after BrdU pulse-labeling in neonatal mice which were chased for at least 12 weeks. The majority of stromal LRC were located near blood vessels, close to the endometrial -myometrial junction (Chan and Gargett, 2006; Cervelló et al., 2007) correlating with their postulated basalis location in human endometrium .
In the last 5 years accumulated evidences confirmed the existence of SP cells in human endometrium, and have indeed demonstrated that the SP technique could be a putative tool for the isolation of human endometrial SSC (Kato et al., 2007; Tsuji et al., 2008; Cervelló et al., 2010 Cervelló et al., , 2011 Cervelló et al., , 2012 Masuda et al., 2010) . The human endometrial SP cells possess high clonogenic efficiency, express undifferentiated genes, and have a mesenchymal stem cell phenotype (presence of CD90, CD105 and CD73). Also, they have the ability to differentiate in vitro to adipogenic, osteogenic and chondrogenic lineages. The final proof of the existence of human endometrial SSC would be demonstrated by the reconstruction of human endometrium in an animal model (Cervelló et al., 2010 (Cervelló et al., , 2011 Masuda et al., 2010) .
Future studies are likely to identify putative endometrial specific markers, allowing the identification and isolation of SSC in this tissue. Candidate tissue specific stem cell surface markers such as PDGF-Rb, CD146 and W5C5 (Gargett et al., 2009; Masuda et al., 2012; Spitzer et al., 2012) were reported in the human stromal cell compartment, but definitive endometrial SSC markers have so far remained elusive. Here, we present published and novel data demonstrating the presence of Lgr5 in the human endometrium and its possible function as an endometrial SSC marker. Table 1 summarizes a number of studies describing lgr5 expression as a stem cell marker in a variety of somatic tissues. In 2007, Clevers' laboratory performed a breakthrough research focused on the identification of the genes responsible for self-renewal in small intestinal mucosa. From 80 genes identified as regulated by Wnt signaling, expression was restricted to intestinal crypt bottoms only in 11 of them (Van der Flier et al., 2007) . Notably one of these genes was expressed in the crypt in a distinctive manner; this gene, termed Leucine-rich repeat-containing heterotrimeric guanine nucleotidebinding protein-coupled receptor (Lgr) 5, is a cell surface receptor that specifically associates with the Frizzled and LPR protein receptors, which are activated by extracellular Wnt molecules to trigger canonical Wnt signaling, thus increasing gene expression. Furthermore, R-spondin (Rspo) protein expression, via Lgr5 receptor interaction, leads to enhanced Wnt activation (de Lau et al., 2011; Fig. 1) .
Lgr5 may be a universal SSC marker
Lgr5 knockout mice are non-viable, their death being caused by gastrointestinal tract dilation and malformations affecting the tongue and lower jaw that result in serious respiratory problems (Morita et al., 2004) . In situ hybridization studies in mice revealed a limited number of Lgr5 cells located at the crypt bottom with an actively cycling nature. This exclusive expression pattern was clearly different from genes marking Paneth or transit amplifying cells (Barker et al., 2007) . The same laboratory generated heterozygous Lgr5-lacZ mice to serve as an in vivo model to identify the restricted expression of Lgr5 through lineage tracing experiments, which seems to mark the cycling base columnar (CBC) cells of the crypt. The cycling nature of the Lgr5 stem cell population is contradictory to the quiescent cell population, located at position +4 in the crypt, until now considered the only stem cell population in the small intestine (Barker et al., 2007) . The coexistence of both populations is regulated by a specific microenvironment in which opposing signaling pathways are either on or off, such as Wnt and BMP, respectively (Li and Clevers, 2010) . Furthermore, this group reproduced the intestinal stem cell niche signals in vitro in a self-renewing 'mini gut' by activation of Wnt and Notch pathways and inhibition of BMP. Using fluorescence-activated cell sorting (FACS) they isolated a unique Lgr5 positive cell population from this in vitro system, demonstrating its functional relevance (Sato et al., 2009) .
Lgr5 cells from mouse intestinal crypts also show significant telomerase activity: a key characteristic of stem cells. After isolation of these cells by FACS, the cell extracts were used to analyze the expression of Tert, the catalytic component of telomerase, by RT -PCR, and were also tested for telomerase activity through the TRAPeze telomerase detection assay. Results showed that cells enriched for Lgr5 expression also have significantly higher Tert mRNA levels and telomerase activity than differentiated cells (Schepers et al., 2011) .
Small intestine mucosa Lgr5 positive cells are actively cycling, retain BrdU labeling, and express Ki67 and phospho-histone H3 (Barker et al., 2007) . In fact, there are significantly increased numbers of Lgr5 cells found in colon and rectum cancers, and this expression is even higher in metastatic tumors compared with primary tumors, suggesting that Lgr5 overexpression is associated with abnormal cellular proliferation and metastasis (Becker et al., 2008; Uchida et al., 2010; Takahashi et al., 2011) . Characteristic features related to endoderm origin, suggest that Lgr5 could also be considered a mucosal stem cell marker in organs such the small intestine, colon and stomach. Lgr5 expression in all these tissues was confined to CBC in the intestinal crypt, the colon crypt base and the base of pyloric glands in the stomach, respectively (Barker et al., 2007; Barker and Clevers, 2010) .
It has also been demonstrated that Lgr5 acts as a hair follicle (i.e. ectodermal origin) stem cell niche marker. Gene expression profile studies documented that Lgr5 expression was enriched in bulge cells and lineage tracing experiments distinguished it in the hair germ during late telogen/early anagen phases, as well as in the hair matrix during the late anagen phase (Morris et al., 2004) . The Lgr5 positive population isolated from the bulge constituted around 0.6% of the parent cell population and in culture they formed large colonies with a high efficiency when compared with Lgr5 negative cells taken from the same population. To test follicle reconstitution, Lgr5 positive cells sorted by FACS were transplanted into nude mice and were able to completely regenerate hair follicles at the transplantation sites (Jaks et al., 2008) .
Lgr5 cells have also been traced in the kidney in Lgr5-enhanced green fluorescent protein-ires-CreERT2 experimental model reporter mice, where they remain restricted to cell subsets within developing nephrons. These cells give rise to the ascending limb of Henle's loop and the distal convoluted tubule in mature nephrons, although this expression was permanently silenced at post-natal Day 7. These data suggest that Lgr5 cells are likely the stem or progenitor cells involved in kidney formation, but their absence in the mature organ might lead to slow cell turnover . Nevertheless tubular epithelial cells also have the capacity to undergo epithelial mesenchymal transition repairing tubular damage (Bussolati and Camussi, 2006) .
Wnt signaling in uterine physiology
The Wnt signaling pathway plays an important role in the maintenance and activation of the stem cell reservoir (Ivanova et are required during embryological development of the female reproductive tract, with Wnt4 and Wnt7a identified as key regulators of female Müllerian duct development (Stark et al., 1994; Vainio et al., 1999) . Wnt9b, which is important in the outgrowth of Müllerian ducts, is transiently expressed (Carroll et al., 2005) and later, Wnt5a and Wnt7a are involved in the proper differentiation of the ducts into uterus, cervix, vagina and oviduct (Miller and Sasson, 1998; Parr and McMahon, 1998) . Indeed, mice deficient for the Wnt7a gene completely lack uterine glands (Miller and Sasoon, 1998) and oviducts in most animals (Parr and McMahon, 1998) , resulting in infertility.
In human endometrium, Wnt7a is specifically located in the luminal epithelium, whereas Wnt5a is restricted to the stromal compartment. No significant regulation of Wnt2, -4, -5a or -7a has been demonstrated in the different phases of the menstrual cycle, with the exception of Wnt3 up-regulation in proliferative endometrium (Tulac et al., 2003) .
Ovarian hormones regulate Wnt signaling in endometrium to maintain the balance between estrogen-induced proliferation and progesterone-driven differentiation (Sonderegger et al., 2010; Van der Horst et al., 2012) . Wnt molecules (-4, -5a, -6 and -7a) are up-regulated by estrogen during the proliferative phase, while in the secretory phase progesterone acts as an activator of Wnt signaling inhibitors (Wang et al., 2010) . Moreover, differential expression of Wnt signaling molecules between pre-and post-menopausal endometrial epithelial cells suggests an epithelial stem cell population residing in the basalis layer . All the evidence gathered suggests that the cyclic remodeling of the endometrium requires epithelial -mesenchymal communication guided by Wnt family members (Tulac et al., 2003) , and that the Wnt signaling pathway participates in stem cell maintenance and differentiation.
Since the relation between Wnt pathway signaling and Lgr5 is clearly established, we hypothesized that a mechanism, similar to the gastrointestinal tract where epithelial cells in the crypts proliferate in response to activated Wnt signaling (Clevers, 2006) , is present in the human endometrium, and that Lgr5 might be a potential SSC marker for these cells. Krusche et al. (2007) described the expression of Lgr5 in the human endometrium, coinciding with Clevers' identification of this protein as a SSC marker in the small intestine and colon. It was demonstrated that Lgr5 was expressed constitutively at mRNA level throughout the menstrual cycle but not at the protein level. Interestingly, Lgr5 expression was higher in endometrial epithelial cells compared with stromal cells and was not hormonally regulated (Krusche et al., 2007) . Sun and collaborators demonstrated that Lgr5 expression in the mouse uterus was dynamic and dependent of the developmental stage of the uterus. Indeed the influence of ovarian hormones in the oscillation of Lgr5 expression revealed that in the presence of estrogen and progesterone, its expression decreased. Furthermore, Lgr5 expression was undetectable in the absence of b-catenin (Sun et al., 2009) in lacZ reporter mice. Despite these findings, the function and regulation of the Lgr5 gene in the uterus remains largely unknown.
Lgr5 cells in the human and murine endometrium
New developments
Stem cell niches are usually identified based on the expression of specific protein markers on SSC that can be tracked and localized. The Lgr5 gene is a multi-pass-membrane protein, with three domains: a large extracellular domain with multiple Leucine-rich repeats that mediate ligand interaction, a transmembrane domain, and an intracellular domain for signal transduction. It may represent a new molecule that can be used as a SSC marker tool. We used in situ hybridization, which allows the localization of specific gene expression within the cellular environment to detect the expression of Lgr5 positive cells in human endometrium throughout the menstrual cycle, using specific riboprobes generated in our laboratory. Our results revealed the existence of Lgr5 positive cells in a restricted epithelial and stromal area, mainly located in the perivascular regions (Fig. 2) .
The telomerase enzyme, which prevents telomere shortening at each cell division, maintains telomere length, and is expressed in stem cells including germ cells and in the niche of several adult tissues. The technique known as telomapping is a type of confocal quantitative fluorescence in situ hybridization which displays the gradient of telomere length that exists inside a given adult tissue (Flores et al., 2008) , where the longest telomere cells are mapped in red, and the shortest are stained in blue. SSC from skin, small intestine, testis, cornea and brain have been investigated in the mouse model in this way (Flores et al., 2008) . Using this technique we identified specific hot regions (red color) in the human endometrium, corresponding to cells with the longest telomeres. Interestingly, we co-localized Lgr5 mRNA signals in some of the cells with the longest telomeres, suggesting that Lgr5 cells are associated, at least in part, with a long telomere phenotype (data not shown).
We also investigated the localization of immunoreactive Lgr5 in the human endometrium throughout the menstrual cycle. As expected, Lgr5 cells were localized in the epithelial glands and perivascular regions of the stromal compartment, with no apparent differences in the frequency or intensity of the signal across the cycle (Fig. 2) . Immunohistochemistry analysis revealed specific signals (cytoplasmic and membrane positions) located in the lower functionalis, near the basalis layer, being most frequently found in stromal cells. The expression of Lgr5 protein was also confirmed by western Blot analysis ( Fig. 2A and B) .
The presence of Lgr5 in human endometrium using mRNA and protein approaches together is a novel finding and combined with our preliminary findings (data not shown) suggesting that it co-localizes in cells with the longest telomeres, we speculate that it may both mark and be implicated in the endometrial SSC niche. Clearly, these preliminary findings require extensive follow-up. Studies already in progress in a xenotransplant model will help elucidate whether endometrial Lgr5 positive cells can reconstruct human endometrium, providing definitive proof of endometrial SSC marker.
Implications for clinical translation and future research
Specific SSC markers have been proposed and demonstrated in different tissues, and hold the key to understanding various physiological and pathological processes in vivo. In addition, their isolation and use in regenerative therapies has major clinical implications.
As demonstrated here Lgr5 is a promising candidate for a specific endometrial SSC marker that may help us to advance our knowledge of the origin of this SSC population and to better understand its role in regenerative mechanisms in health and disease. We expect that the main translational contributions from this work will be the implementation of novel therapeutic approaches to currently incurable pathological situations such as Asherman's syndrome or endometrial atrophy, or to further investigate how endometriosis might be related to abnormal Lgr5 expression is associated with the ectopic growth and tissue maintenance that characterize this disease. Constitutively activated Wnt signaling can stimulate abnormal cell proliferation resulting in endometrial hyperplasia, which can progress to endometrial cancer (Gunin et al., 2004; Polotsky et al., 2009) . Endometriosis is an estrogen-dependent disease, and high Wnt7a expression in endometrial tissues induces HOXA10 expression (Zanatta et al., 2010) . We therefore speculate that the enhanced activation of this pathway may be a mechanism that stimulates the proliferation and invasion of endometrial cells.
With the ultimate goal of creating a functional tissue-engineered human endometrium, based on cellular repopulation of decellularized extracellular matrices or biomaterial scaffolds, it is crucial that a 'bona fide' stem cell marker is identified that can be used to isolate endometrial SSC. Although currently under investigation by several groups, the actions of the Wnt and b-catenin signaling pathways in endometrial pathologies are still not well understood, which may impede such bioengineering efforts. However, the search for specific markers like Lgr5 remains the next frontier to the advancement of the endometrial research field. 
